A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Targeted Cancer Therapeutics," features profiles of Coronado Biosciences, Emiliem and SynDevRx. Plus these Start-Ups Across Health Care: Activaero, Chakshu Research, Myomo and Valor Medical.

Valor Medical treats cerebral aneurysms with Neucrylate, which is injected through a microinfusion catheter introduced into the femoral artery of the leg, then passed up through the arterial system into the brain. Neucrylate is slowly delivered to the aneurysm in liquid form via a syringe. Once the product makes contact with blood, it immediately polymerizes into a soft, spongy solid to permanently relieve the blood pressure of the vessel wall of the aneurysm.